Guy Wendy 4

What Happened
Wendy Guy, Chief Administrative Officer of Processa Pharmaceuticals (PCSA), reported an open-market purchase of 1,583 shares on May 15, 2026 at $2.97 per share, for a total reported cost of $4,702. This Form 4 shows a purchase (transaction code P), which is a direct buy of company stock.

Key Details

• Transaction date and price: May 15, 2026 — 1,583 shares at $2.97 each (total $4,702).
• Transaction type: Purchase (P) — reported as an open-market or private purchase.
• Shares owned after transaction: Not disclosed in this filing.
• Filing timeliness: Form 4 was filed on May 19, 2026 (timely given the May 15 transaction).
• Footnote: The filing corrects immaterial errors from an earlier Form 4 (filed May 1, 2026). The April 30, 2026 purchase price was corrected to $2.71 (not $2.69), which reduces that April 30 purchase count by 13 shares.

Context
Insider purchases are often watched by investors as a positive signal, though this transaction is small in dollar value (~$4.7k) and should be considered alongside other filings and company news. The footnote correction is administrative and affects an earlier April 30 purchase record rather than this May 15 trade.